Home > Financial Ratios > AJANTA PHARMA

AJANTA PHARMA
Core EBITDA Margin

    Back to All Ratios
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Margin(%) 20.6427.3733.8526.4027.56

What is the latest Core EBITDA Margin ratio of AJANTA PHARMA ?

The latest Core EBITDA Margin ratio of AJANTA PHARMA is 20.64 based on Mar2023 Consolidated results.
Year Core EBITDA Margin
Mar202320.64
Mar202227.37
Mar202133.85
Mar202026.40
Mar201927.56

How is Core EBITDA Margin of AJANTA PHARMA Trending?

Years Core EBITDA Margin % Change
Mar2023 20.64
-24.59
Mar2022 27.37
-19.14
Mar2021 33.85
28.22
Mar2020 26.4
-4.21
Mar2019 27.56 -

Other Financial Ratios of AJANTA PHARMA


Compare Core EBITDA Margin ratio of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹27,924.0 Cr 4.1% 1.6% 72.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,452.0 Cr 1.1% -6.6% 56.7% Stock Analytics
CIPLA ₹113,132.0 Cr 0.2% -4.4% 54.3% Stock Analytics
DIVIS LABORATORIES ₹106,191.0 Cr 4.8% 18.9% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,512.0 Cr 4.3% 2.6% 29.9% Stock Analytics
ZYDUS LIFESCIENCES ₹95,954.5 Cr 2.2% -4.6% 86.6% Stock Analytics


AJANTA PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

4.1%

1.6%

72.6%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses